Feb 09, 2016 12:00 pm UTC| Business
BOSTON, Feb. 09, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new cancer immunotherapies, today announced that the first patient has been enrolled in a Phase 1 clinical study of...
Cambrex Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 09, 2016 12:00 pm UTC| Business
- 2015 Sales and EBITDA increased 16% and 57% respectively vs. prior year - - Continued strong sales and EBITDA growth expected in 2016 - - Conference call at 8:30 a.m. ET on February 9, 2016 - EAST RUTHERFORD, N.J.,...
Feb 09, 2016 12:00 pm UTC| Business
ATLANTA, Feb. 09, 2016 -- Apogee Interactive today announced that it is expanding its partnership program beyond offering integrated customer service solutions to providing analytical tool sets that will improve...
Feb 09, 2016 12:00 pm UTC| Business
RICHARDSON, Texas, Feb. 09, 2016 -- Fossil Group, Inc. (NASDAQ:FOSL) announced today that its earnings for the fiscal fourth quarter ended January 2, 2016 will be released following the market close on Tuesday, February...
Feb 09, 2016 11:50 am UTC| Business
PHOENIX, Feb. 09, 2016 -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced that the Company has enrolled the first patient in a Phase II clinical study for the treatment of infantile...
Crown Crafts Reports Fiscal 2016 Third Quarter Results
Feb 09, 2016 11:45 am UTC| Business
Net income and gross margin improve for the quarter and year to dateCompany reports cash balance of $7.5 million at quarter endBoard declares special dividend of $0.25 per share in addition to a quarterly dividend of $0.08...
Fifth Street Finance Corp. Announces Quarter Ended December 31, 2015 Financial Results
Feb 09, 2016 11:30 am UTC| Business
GREENWICH, CT, Feb. 09, 2016 -- Fifth Street Finance Corp. (NASDAQ:FSC) ("FSC" or "we") announces its financial results for the first fiscal quarter ended December31, 2015. First Fiscal Quarter 2016 and Post-Quarter...